Skip to content

Clinical trials

Completed Phase 2 Glucose Intolerance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Phase 2 Status: Completed Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20051
20061
20072
20082
20096
20102
20114
20121
20131
20141
20152
20161
20191
20202
20214
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genfit2
National Heart, Lung, and Blood Institute (NHLBI)2
Novartis Pharmaceuticals2
University of Guadalajara2
AdventHealth Translational Research Institute1
Aphaia Pharma US LLC1
Arete Therapeutics1
Assistance Publique - Hôpitaux de Paris1
Brigham and Women's Hospital1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance38
Insulin Resistance11
Obesity10
Diabetes Mellitus, Type 26
Metabolic Syndrome6
Prediabetic State4
Hypertension3
Obesity, Abdominal3
Atherosclerosis2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.